BioLife Solutions to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Business Update on March 8, 2018

BOTHELL, Wash., March 1, 2018

To access the webcast, log on to the Investor Relations page of the BioLife Solutions website at www.biolifesolutions.com. Alternatively, you may access the live conference call by dialing (844) 825-0512 (U.S. & Canada) or (315) 625-6880 (International) with the following Conference ID:   8488316. A webcast replay will be available approximately two hours after the call and will be archived on www.biolifesolutions.com for 90 days.

About BioLife Solutions

BioLife Solutions is the leading developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. Our proprietary HypoThermosol® and CryoStor® platform of biopreservation media products are highly valued in the regenerative medicine, biobanking and drug discovery markets. These are serum-free, protein-free, fully defined, and formulated to reduce preservation-induced cell damage and death. Our enabling, embeddable technologies provide commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.

For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

Media & Investor Relations ARIVA.DE Börsen-Geflüster Kurse BioLife Solutions 17,06 $ +1,19%
Roderick de Greef
Chief Financial Officer
(425) 402-1400
rdegreef@biolifesolutions.com

View original content with multimedia:http://www.prnewswire.com/news-releases/biolife-solutions-to-report-fourth-quarter-and-full-year-2017-financial-results-and-provide-business-update-on-march-8-2018-300607070.html

SOURCE BioLife Solutions, Inc.